GC Green Cross Wellbeing Launches ECM Skin Booster, Strengthening Its Position in Aesthetics

Official Launch of Giselle Ribonne in Korea

hADM-Based ECM Booster Supports Structural Skin Regeneration

On March 25, GC Green Cross Wellbeing announced the official launch of its human tissue-based extracellular matrix (ECM) skin booster, 'Giselle Ribonne (GCELLE RIBONNE)'.

'Giselle' is GC Green Cross Wellbeing's proprietary integrated aesthetic brand. Its first product, Giselle Ribonne, embodies the concept of 'rebirth', emphasizing the value of supporting healthy skin renewal through ECM ingredients.

GC Green Cross Wellbeing ECM Skin Booster 'Giselle Rebonne'. GC Green Cross Wellbeing

Recently, the aesthetics market has been shifting away from simple volume enhancement or moisture-focused procedures, toward treatments that regenerate and restore the structure of skin tissue itself. In line with these market changes, GC Green Cross Wellbeing aims to introduce a new paradigm in aesthetics focused on structural regeneration through the Giselle brand.

Giselle Ribonne is an ECM booster based on human-derived acellular dermal matrix (hADM). While conventional skin boosters typically induce the production of collagen—the framework of the ECM—Giselle Ribonne directly delivers the ECM structure itself, providing a foundation for tissue reformation.

The processing of human tissue is handled by MSBio, a specialist in human tissue and biomaterials. GC Green Cross Wellbeing has established a raw material management and supply system based on its tissue bank at the Eumseong plant in North Chungcheong Province. Using MSBio’s proprietary technology, a decellularization process removes cells and immune response-triggering agents from the tissue, increasing biocompatibility and minimizing the risk of immune rejection and inflammation.

With the launch of Giselle Ribonne, GC Green Cross Wellbeing plans to establish a differentiated premium regenerative category based on ECM, further strengthening its position in the aesthetics market. The company also aims to transition into an integrated medical aesthetics platform provider, leveraging a product portfolio that includes the placenta injection Laennec, fillers, skin boosters, and botulinum toxin.

Sanghyun Kim, CEO of GC Green Cross Wellbeing, stated, "As the aesthetics market shifts from a focus on function to structural regeneration, we will set new standards and steadily build our competitiveness in the global market."

This content was produced with the assistance of AI translation services.